SYNLOGIC, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
SYNLOGIC, INC. (SYBX) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $20.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-03-12
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $20.00K.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $30.00K.
- 2025-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $40.00K.
- 2025-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $50.00K.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2025-12-31 | $20.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $30.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $40.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $50.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $100.00K 10-K · filed 2025-03-06 |
| 2024-09-30 | $300.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $300.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $700.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $3.20M 10-K · filed 2024-03-19 |
| 2023-09-30 | $3.90M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $4.50M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $5.90M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $4.90M 10-K · filed 2023-03-29 |
| 2022-09-30 | $6.10M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $6.60M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $7.50M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $5.20M 10-K · filed 2022-03-17 |
| 2021-09-30 | $6.00M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $6.50M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $6.90M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $4.30M 10-K · filed 2021-03-25 |
| 2020-09-30 | $5.20M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $5.50M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $6.90M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $6.80M 10-K · filed 2020-03-12 |
| 2019-09-30 | $8.70M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $10.70M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $12.70M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $8.40M 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |